Dyne Therapeutics, Inc.DYNNASDAQ
LOADING
|||
EBITDA Over Time
Trending lower, below historical average.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-315.18M
↓ 472% below average
Average (9y)
$84.64M
Historical baseline
Range
High:$949.00M
Low:$-315.18M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-315.18M | -35.0% |
| 2023 | $-233.48M | -37.9% |
| 2022 | $-169.28M | -13.7% |
| 2021 | $-148.94M | -155.3% |
| 2020 | $-58.34M | -299.9% |
| 2019 | $-14.59M | -204.7% |
| 2018 | $-4.79M | -100.5% |
| 2017 | $949.00M | +795.3% |
| 2016 | $106.00M | -85.6% |
| 2015 | $736.00M | - |